Dr. Yasir Raji
MD and CEO
Notable Quotes
We expect the contribution from the non-GPL business to continue to increase going forward.
We remain confident in our ability to sustain EBITDA margins in the range of 30 to 32%.
Maintaining a high quality business is a much bigger priority for Alivus. Growth will not be pursued at the cost of margins.